We are live on
!
Find out more
KCM
Kingdon Capital Management Portfolio holdings
AUM
$911M
1-Year Est. Return
51.11%
This Fund
S&P 500
This Quarter
Est. Return
+0.24%
1 Year Est. Return
+51.11%
3 Year Est. Return
+185.44%
5 Year Est. Return
+284.29%
10 Year Est. Return
+2,022.7%
AUM
$782M
AUM Growth
+$192M
(+33%)
Cap. Flow
+$233M
Cap. Flow
% of AUM
29.84%
Top 10 Holdings %
Top 10 Hldgs %
65.23%
Holding
93
New
24
Increased
13
Reduced
10
Closed
33
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baxter International
BAX
|
+$28.9M |
| 2 |
Elevance Health
ELV
|
+$19.6M |
| 3 |
BWX Technologies
BWXT
|
+$18.1M |
| 4 |
Edwards Lifesciences
EW
|
+$13.6M |
| 5 |
Ferguson
FERG
|
+$12.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$19.8M |
| 2 |
Humana
HUM
|
+$19.6M |
| 3 |
Centene
CNC
|
+$13.9M |
| 4 |
Bloomin' Brands
BLMN
|
+$11.9M |
| 5 |
GTLS
Chart Industries
GTLS
|
+$9.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.01% |
| 2 | Industrials | 8.99% |
| 3 | Financials | 4.7% |
| 4 | Consumer Discretionary | 3.83% |
| 5 | Technology | 2.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Tenet Healthcare
THC
$21.1B
| $6.71M | 0.86% |
+130,000
| New | +$7.72M |
|
27
Guardant Health
GH
$22.6B
| $6.63M | 0.85% |
+123,100
| New | +$6.32M |
|
28
CALL
Rapid7
RPD
$773M
| $6.11M | 0.78% |
+142,500
| New | +$8.8M |
|
29
Beyond Air
XAIR
$3.86M
| $5.92M | 0.76% |
1,990
+39
| +2% | +$146K |
|
|
DFS
30
DELISTED
Discover Financial Services
DFS
| $5.46M | 0.7% |
60,000
-5,000
| -8% | -$506K |
|
|
SBNY
31
DELISTED
Signature Bank
SBNY
| $4.91M | 0.63% |
32,500
-2,500
| -7% | -$454K |
|
|
DOCU
32
CALL
DocuSign
DOCU
$11.5B
| $4.28M | 0.55% |
+80,000
| New | +$5.02M |
|
33
Sol-Gel Technologies
SLGL
$288M
| $4.18M | 0.53% |
83,280
| – | – |
|
|
TPIC
34
DELISTED
TPI Composites
TPIC
| $3.95M | 0.51% |
+350,000
| New | +$5.53M |
|
35
Inspire Medical Systems
INSP
$1.74B
| $3.73M | 0.48% |
+21,000
| New | +$4.22M |
|
|
36
PUT
Rapid7
RPD
$773M
| $3.43M | 0.44% |
+80,000
| New | +$4.94M |
|
37
Blackstone
BX
$110B
| $3.35M | 0.43% |
40,000
+15,000
| +60% | +$1.45M |
|
|
SI
38
PUT
DELISTED
Silvergate Capital Corporation
SI
| $3.34M | 0.43% |
+44,300
| New | +$3.77M |
|
39
SCYNEXIS
SCYX
$52M
| $3.11M | 0.4% |
162,131
| – | – |
|
|
WNS
40
DELISTED
WNS Holdings
WNS
| $3.07M | 0.39% |
37,500
-13,374
| -26% | -$1.11M |
|
|
MSAC
41
DELISTED
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
| $2.97M | 0.38% |
300,000
| – | – |
|
42
Apollo Global Management
APO
$73.4B
| $2.79M | 0.36% |
60,000
| – | – |
|
43
Great Elm Group
GEG
$69.3M
| $2.76M | 0.35% |
1,379,049
| – | – |
|
44
Praxis Precision Medicines
PRAX
$10.1B
| $2.62M | 0.34% |
77,066
| – | – |
|
45
Carlyle Group
CG
$17.2B
| $2.58M | 0.33% |
100,000
+25,000
| +33% | +$823K |
|
46
DXC Technology
DXC
$1.73B
| $2.45M | 0.31% |
+100,000
| New | +$2.75M |
|
|
BBBY
47
Bed Bath & Beyond
BBBY
$442M
| $2.44M | 0.31% |
110,000
+27,500
| +33% | +$689K |
|
|
EUCR
48
DELISTED
Eucrates Biomedical Acquisition Corp. Ordinary Shares
EUCR
| $2M | 0.26% |
200,000
| – | – |
|
49
Curis
CRIS
$7.83M
| $1.77M | 0.23% |
6,311
+1,500
| +31% | +$605K |
|
|
50
PUT
DXC Technology
DXC
$1.73B
| $1.71M | 0.22% |
+70,000
| New | +$1.92M |
|
Similar funds
GC
ICP
SAA
GIG
SI
PAMI
BDP
PTC
Kingdon Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, Kingdon Capital Management held 93 positions worth $782M, up 33% from $589M the previous quarter. Its ten largest holdings account for 65% of the portfolio.
Kingdon Capital Management deployed $233M of net new capital in Q3 2022, opening 24 new positions and adding to 13 existing holdings. Its largest new stake was Baxter International: 480,500 shares worth $25.9M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 21% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was RAPT Therapeutics, an estimated $8.22M trimmed.
- Kingdon Capital Management's largest Q3 2022 buy was Baxter International: 480,500 shares worth $25.9M.
- Kingdon Capital Management added most to Palo Alto Networks in Q3 2022, an estimated $4.76M increase.
- Kingdon Capital Management's biggest Q3 2022 reduction was RAPT Therapeutics, cutting an estimated $8.22M.
- Kingdon Capital Management fully exited Meta Platforms (Facebook) in Q3 2022, selling an estimated $19.8M.
- Kingdon Capital Management's ten largest holdings make up 65% of its $782M portfolio in Q3 2022.
- Kingdon Capital Management opened 24 new positions and closed 33 in Q3 2022.
- Kingdon Capital Management's portfolio value rose 33% quarter-over-quarter to $782M.
Based on Kingdon Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.